The store will not work correctly when cookies are disabled.
N-(5-fluoropyridin-2-yl)-6-(1-(pyrimidin-5-yl)ethyl)quinoline-8-carboxamide
ID: ALA4205276
Chembl Id: CHEMBL4205276
PubChem CID: 118400883
Max Phase: Preclinical
Molecular Formula: C21H16FN5O
Molecular Weight: 373.39
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CC(c1cncnc1)c1cc(C(=O)Nc2ccc(F)cn2)c2ncccc2c1
Standard InChI: InChI=1S/C21H16FN5O/c1-13(16-9-23-12-24-10-16)15-7-14-3-2-6-25-20(14)18(8-15)21(28)27-19-5-4-17(22)11-26-19/h2-13H,1H3,(H,26,27,28)
Standard InChI Key: FIROGCUAKZZTOA-UHFFFAOYSA-N
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 373.39 | Molecular Weight (Monoisotopic): 373.1339 | AlogP: 3.96 | #Rotatable Bonds: 4 |
Polar Surface Area: 80.66 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 3.00 | CX LogP: 3.20 | CX LogD: 3.20 |
Aromatic Rings: 4 | Heavy Atoms: 28 | QED Weighted: 0.59 | Np Likeness Score: -1.43 |
References
1. Felts AS, Rodriguez AL, Morrison RD, Blobaum AL, Byers FW, Daniels JS, Niswender CM, Conn PJ, Lindsley CW, Emmitte KA.. (2018) Discovery of 6-(pyrimidin-5-ylmethyl)quinoline-8-carboxamide negative allosteric modulators of metabotropic glutamate receptor subtype 5., 28 (10): [PMID:29705142] [10.1016/j.bmcl.2018.04.053] |